Seven Eight Capital LP grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 57.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 67,049 shares of the medical instruments supplier’s stock after buying an additional 24,584 shares during the period. Seven Eight Capital LP’s holdings in DENTSPLY SIRONA were worth $1,670,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Principal Securities Inc. acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at $26,000. LRI Investments LLC raised its position in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $32,000. Central Pacific Bank Trust Division acquired a new stake in DENTSPLY SIRONA during the first quarter worth approximately $64,000. Finally, Mather Group LLC. purchased a new stake in DENTSPLY SIRONA in the 1st quarter worth approximately $72,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have weighed in on the company. Barrington Research reissued an “outperform” rating and set a $38.00 price target on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Stifel Nicolaus dropped their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Needham & Company LLC reissued a “buy” rating and issued a $34.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Finally, Evercore ISI dropped their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $33.44.
DENTSPLY SIRONA Trading Up 0.1 %
NASDAQ XRAY opened at $26.71 on Thursday. The firm has a market capitalization of $5.41 billion, a price-to-earnings ratio of -60.70, a PEG ratio of 1.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. DENTSPLY SIRONA Inc. has a one year low of $23.58 and a one year high of $37.60. The company’s 50 day moving average price is $25.52 and its 200 day moving average price is $27.96.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last issued its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The business had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business’s revenue was down 4.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.51 EPS. On average, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current year.
DENTSPLY SIRONA Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.40%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA’s payout ratio is -145.45%.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- How Much Can You Make in Stocks in One Month?
- What Are the U.K. Market Holidays? How to Invest and Trade
- This Is the Top Large-Cap Stock Insiders Are Buying
- The Basics of Support and Resistance
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.